Market Research Reports and Industry Reports

Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Canada represents the worlds ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and constant efforts by the government and health care service providers to control their healthcare expenditures have enabled generics to represent a multibillion dollar industry in Canada.

The report entitled Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Key Questions Answered:

What are generic drugs? How are they different from branded drugs?
How has the Canadian generic drug market performed in recent years?
How have generics performed compared to branded drugs?
What were the total sales and prescriptions for generic drugs in Canada?
Who are the key players in the Canadian generic drug market? How have they performed?
What is the structure of the generic drug market in Canada?
What is the pricing mechanism of generic drugs in Canada?
What is the value chain of generic drugs in Canada?
What are the regulations for generic drugs in Canada?
How are generic drugs distributed in Canada?
How are generic drugs manufactured?
What are the raw material and machinery requirements to manufacture generic drugs?
What are the drivers and challenges in the generic drug market in Canada?
1 Research Methodology and Market Definitions
2 Report Summary
3 Canada Generic Drug Market - Introduction
3.1 What are Generics?
3.2 Unbranded and Branded Generics
3.3 Authorized Generics
3.4 Specialty Generics
4 Why is the Generic Drug Market so Lucrative in Canada
4.1 Blockbuster Drugs Facing Patent Expiration
4.2 Substantial Price Difference Between Branded and Generic Drugs
4.3 Government Incentives
4.4 Savings for Drug Purchasers
4.5 Biosimilars
4.6 Ageing Population and Increasing Prevalence of Life Style Diseases
5 Global Generic Drug Market
5.1 Current and Historical Market Trends
5.2 Market Breakup by Country
5.3 Market Forecast
5.4 Most Prescribed Generic and Branded Drugs
6 Canada Generic Drug Market
6.1 Canada Pharmaceutical Market Current, Historical and Future Sales Trends
6.2 Canada Pharmaceutical Market Current, Historical and Future Volume Trends
6.3 Canada Pharmaceutical Market - Share of Branded and Generic Drugs
6.4 Canada Generic Drug Market Current, Historical and Future Sales Trends
6.5 Canada Generic Drug Market Current, Historical and Future Volume Trends
7 Canada Generic Drug Market- Competitive Landscape
7.1 Canada Generic Drug Market - Competitive Structure
7.2 Canada Generic Drug Market - Sales Breakup of Key Players
7.3 Canada Generics Distribution Breakup by Channel
7.4 Canada Generic Drug Market Average Retail Price Per Prescription (Generic vs. Branded)
8 Canada Generic Drug Market - Value Chain Analysis
8.1 Research and Development
8.2 Manufacturing
8.3 Marketing
8.4 Distribution
9 Canada Generic Drug Market Regulatory Framework
9.1 Overview of Pharmaceutical Regulations
9.2 Pre-Market Drug Submission Requirements for Generic Drugs
9.3 Review Process for Generic Drugs
9.4 Generic Drug Approval and Declaration of Its Bioequivalence
9.5 Other Important Considerations
10 Canada Generic Drug Market: Key Success Factors
11 Canada Generic Drug Market: Road Blocks
12 Requirements for Setting Up a Generic Drug Manufacturing Plant
12.1 Manufacturing Process
12.2 Raw Material Requirements
12.3 Machinery and Infrastructure Requirements
13 Canada Generic Drug Market - Key Company Profiles
13.1 Teva Pharmaceutical Ltd.
13.2 Apotex Inc.
13.3 Sandoz Canada
13.4 Actavis
13.5 Mylan
13.6 Pharmascience Inc.
13.7 Taro Pharmaceuticals
13.8 Novartis
13.9 Ranbaxy Pharmaceuticals Canada
13.10 Hospira

List Of Tables

Table 4 1: Canada: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 5 1: Global: Generic Drug Market: Sales Volume and Growth of Major Markets, 2014
Table 5 2: Global: Generic Drug Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2015
Table 5 3: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions), 2015
Table 7 1: Canada: Distribution of Generic Drugs: Breakup by Channel (in %), 2015

List Of Figures

Figure 3 1: Structure of the Pharmaceutical Industry
Figure 3 2: Classification of Generic Drugs
Figure 4 1: Canada: Patent Expiry Exposure (in Billion US$), 2009-2016
Figure 4 3: Canada: Savings from Generic Drugs (in Billion US$), 2010-2015
Figure 5 1: Global: Generic Drug Market: Sales Value (in Billion US$), 2010-2015
Figure 5 2: Global: Generic Drug Market: Sales Volume (in Billion Units), 2010-2015
Figure 5 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2015
Figure 5 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2015
Figure 5 5: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2016-2021
Figure 5 6: Global: Generic Drug Market: Sales Volume (in Billion Units), 2016-2021
Figure 6 1: Canada: Pharmaceutical Market: Sales Value (in Billion US$), 2010-2015
Figure 6 3: Canada: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2016-2021
Figure 6 2: Canada: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2010-2015
Figure 6 4: Canada: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2016-2021
Figure 6 5: Canada: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2010 and 2015
Figure 6 6: Canada: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2010 and 2015
Figure 6 7: Canada: Generic Drug Market: Sales Value (in Billion US$), 2010-2015
Figure 6 8: Canada: Generic Drug Market Forecast: Sales Value (in Billion US$), 2016-2021
Figure 6 9: Canada: Generic Drug Market: Sales Volume (in Million Prescriptions), 2010-2015
Figure 6 10: Canada: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2016-2021
Figure 7 1: Canada: Generic Drug Market: Sales Breakup of Key Players (in %), 2015
Figure 7 2: Canada: Generic Drug Market: Average Retail Price Per Prescription (Generics vs. Branded- in US$ Per Prescription), 2008-2015
Figure 8 1: Canada: Generic Drug Market Value Chain Analysis
Figure 9 1: Canada: Generic Drug Market: Regulatory Framework for Generic Drugs

International Canada, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

International Canada, Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

HSBC Securities Canada), Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

HSBC Securities Canada), Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Government of Canada Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Government of Canada Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

United States Inhalation & Nasal Spray Generic Drugs Market Report 2016

Notes:Sales, means the sales volume of Inhalation & Nasal Spray Generic DrugsRevenue, means the sales value of Inhalation & Nasal Spray Generic DrugsThis report studies sales (consumption) of Inhalation &

USD 3800View Report

United States Inhalation Nasal Spray Generic Drugs Market Report 2016

Notes:Sales, means the sales volume of Inhalation Nasal Spray Generic DrugsRevenue, means the sales value of Inhalation Nasal Spray Generic DrugsThis report studies sales (consumption) of Inhalation Nasal Spray Generic

USD 3800View Report

Europe Generic drug Market Report 2016

Notes:Sales, means the sales volume of Generic drugRevenue, means the sales value of Generic drugThis report studies sales (consumption) of Generic drug in Europe market, especially in Germany, UK, France,

USD 3900View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 1200
  • Site Licence    $ 1500
  • Enterprisewide Licence    $ 1500
  • Hard Copy    $ 1400
  • CD    $ 1400
$ 1200

Reports Details

Published Date : May 2016
No. of Pages :71
Country :Canada
Category :Healthcare
Publisher :IMARC Group
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment